In this CE activity, expert faculty identify biomarkers in DME that may predict inflammation and aid in measuring treatment response. They also examine the use of combination therapy early in the course of disease to reduce vision loss and improve patient outcomes.
- Provider:Vindico Medical Education, LLC
- Activity Link: https://cme.healio.com/ophthalmology/20240307/improving-dme-treatment-using-biomarkers-and-early-combination-therapy/overview
- Start Date: 2024-03-31 05:00:00
- End Date: 2024-03-31 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: Source: AbbVie Inc. - Amount: 40607.5 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest